124 related articles for article (PubMed ID: 6246948)
1. Production and characterization of antibody blocking epidermal growth factor:receptor interactions.
Haigler HT; Carpenter G
Biochim Biophys Acta; 1980 May; 598(2):314-25. PubMed ID: 6246948
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells.
Massagué J
J Biol Chem; 1983 Nov; 258(22):13614-20. PubMed ID: 6315706
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity.
Cohen S; Carpenter G; King L
J Biol Chem; 1980 May; 255(10):4834-42. PubMed ID: 6246084
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody that immunoreacts with a subclass of human receptors for epidermal growth factor.
Behzadian MA; Shimizu N
Cell Struct Funct; 1985 Sep; 10(3):219-32. PubMed ID: 2994889
[TBL] [Abstract][Full Text] [Related]
5. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
Sato JD; Kawamoto T; Le AD; Mendelsohn J; Polikoff J; Sato GH
Mol Biol Med; 1983 Dec; 1(5):511-29. PubMed ID: 6094961
[TBL] [Abstract][Full Text] [Related]
6. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
7. Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor.
Massague J; Czech MP; Iwata K; DeLarco JE; Todaro GJ
Proc Natl Acad Sci U S A; 1982 Nov; 79(22):6822-6. PubMed ID: 6294655
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor: biological activity requires persistent occupation of high-affinity cell surface receptors.
Shechter Y; Hernaez L; Cuatrecasas P
Proc Natl Acad Sci U S A; 1978 Dec; 75(12):5788-91. PubMed ID: 215996
[TBL] [Abstract][Full Text] [Related]
9. Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells.
Schreiber AB; Schlessinger J; Edidin M
J Cell Biol; 1984 Feb; 98(2):725-31. PubMed ID: 6319431
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
Claudio T; Raftery MA
J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic activity of the epidermal growth factor receptor after transfer from A431 carcinoma cells to receptor-negative fibroblastic cells.
Das M; Biswas R; Basu M; Bishayee S
Cancer Res; 1984 Aug; 44(8):3539-45. PubMed ID: 6331651
[TBL] [Abstract][Full Text] [Related]
12. Biological properties of antibodies against rat adipocyte intrinsic membrane proteins. Dependence on multivalency for insulin-like activity.
Pillion DJ; Grantham JR; Czech MP
J Biol Chem; 1979 May; 254(9):3211-20. PubMed ID: 107169
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody to the type 1 insulin-like growth factor and insulin receptors stimulates deoxyribonucleic acid synthesis in human and murine fibroblasts.
Cara JF; Stuart CA; Furlanetto RW
Endocrinology; 1988 Sep; 123(3):1341-7. PubMed ID: 2969801
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody which inhibits epidermal growth factor binding has opposite effects on the biological action of epidermal growth factor in different cells.
Chandler LP; Chandler CE; Hosang M; Shooter EM
J Biol Chem; 1985 Mar; 260(6):3360-7. PubMed ID: 2982858
[TBL] [Abstract][Full Text] [Related]
15. Interactions between the receptors for platelet-derived growth factor and epidermal growth factor.
Bowen-Pope DF; Dicorleto PE; Ross R
J Cell Biol; 1983 Mar; 96(3):679-83. PubMed ID: 6300138
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-receptor-protein kinase interactions.
Cohen S; Carpenter G; King L
Prog Clin Biol Res; 1981; 66 Pt A():557-67. PubMed ID: 6273929
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.
Carpenter G; Stoscheck CM; Preston YA; DeLarco JE
Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5627-30. PubMed ID: 6310584
[TBL] [Abstract][Full Text] [Related]
18. Properties of receptors for epidermal growth factor in detergent solution: evidence for heterogeneous aggregated states.
Linsley PS; Fox CF
J Supramol Struct; 1980; 14(4):511-25. PubMed ID: 6264235
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic domains of the epidermal growth factor receptor of human placenta.
O'Keefe EJ; Battin T; Bennett V
J Supramol Struct Cell Biochem; 1981; 15(1):15-27. PubMed ID: 6265704
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J
Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
